HSPG2

Chr 1

heparan sulfate proteoglycan 2

Also known as: HSPG, PLC, PRCAN, SJA, SJS, SJS1

The perlecan protein is an integral component of basement membranes that provides structural support, regulates vascular barrier function, and localizes acetylcholinesterase at neuromuscular junctions. Biallelic mutations cause Schwartz-Jampel syndrome type 1 (characterized by muscle stiffness and skeletal abnormalities) and Silverman-Handmaker type dyssegmental dysplasia (a severe skeletal dysplasia), both inherited in an autosomal recessive pattern. This gene is highly constrained against loss-of-function variants, reflecting its essential role in development and tissue integrity.

GeneReviewsResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismLOEUF 0.41
Clinical SummaryHSPG2
🧬
Gene-Disease Validity (ClinGen)
Schwartz-Jampel syndrome type 1 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.34) despite low pLI — interpret in context.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 253 VUS of 500 total submissions
📖
GeneReview available — HSPG2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.41LOEUF
pLI 0.000
Z-score 9.23
OE 0.34 (0.280.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.14Z-score
OE missense 0.94 (0.910.97)
2571 obs / 2738.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.34 (0.280.41)
00.351.4
Missense OE0.94 (0.910.97)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 78 / 228.6Missense obs/exp: 2571 / 2738.4Syn Z: -1.39
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveHSPG2-related dyssegmental dysplasia, Silverman-Handmaker typeLOFAR
definitiveHSPG2-related Schwartz-Jampel syndromeLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7228th %ile
GOF
0.5661th %ile
LOF
0.3355th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic6
VUS253
Likely Benign153
Benign3
5
Pathogenic
6
Likely Pathogenic
253
VUS
153
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
0
0
0
5
Likely Pathogenic
4
0
2
0
6
VUS
1
241
8
3
253
Likely Benign
0
4
63
86
153
Benign
0
0
3
0
3
Total102457689420

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HSPG2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →